|
業務類別
|
-- |
|
業務概覽
|
Akeso Inc is an investment holding company. The Company's subsidiaries were involved in research and development, production, and commercialization of biopharmaceutical products. The company currently has a pipeline of over 30 drugs for the treatment of diseases like cancers, autoimmune diseases, inflammation, and metabolic diseases, 17 of which have entered the clinical stage, including two first-in-class bi-specific antibody drugs (PD-1/CTLA-4 and PD-1/VEGF). The majorityof the company's revenue is earned in Mainland China, and also has its presence in USA and Other regions. |
| 公司地址
| No. 6, Shennong Road, Torch Development Zone, Guangdong Province, Zhongshan, CHN, 528437 |
| 電話號碼
| +86 76089873998 |
| 傳真號碼
| +86 76089873900 |
| 公司網頁
| https://www.akesobio.com |
| 員工數量
| 3035 |
| Dr. Peng Zhang |
Director and Senior Vice President |
-- |
29/04/2025 |
| Dr. Yu Xia |
Chairman of the Board, President and Chief Executive Officer |
-- |
29/04/2025 |
| Dr. Baiyong Li |
Director, Vice President and Chief Scientific Officer |
-- |
29/04/2025 |
| Dr. Zhongmin Maxwell Wang |
Director and Senior Vice President |
-- |
29/04/2025 |
|
|
| Mr. Bo Tan |
Independent Director |
29/04/2025 |
| Dr. Peng Zhang |
Director and Senior Vice President |
29/04/2025 |
| Mr. Ronggang Xie |
Director |
29/04/2025 |
| Dr. Yu Xia |
Chairman of the Board, President and Chief Executive Officer |
29/04/2025 |
| Dr. Baiyong Li |
Director, Vice President and Chief Scientific Officer |
29/04/2025 |
| Dr. Zhongmin Maxwell Wang |
Director and Senior Vice President |
29/04/2025 |
| Dr. Junwen Zeng |
Independent Director |
29/04/2025 |
| Dr. Yan Xu |
Independent Director |
29/04/2025 |
|
|
|
|
